Predictors of symptomatic remission in first-episode psychosis outpatients treated with quetiapine: A naturalistic study

References

• Andreasen NC, Carpenter WT, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 2005;162:441–9.
   PubMed Web of Science ®Google Scholar
• Boter H, Peuskens J, Libiger J, Fleischhacker WW, Davidson M, Galderisi S et al.; EUFEST study group. Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: an open randomized clinical trial (EUFEST). Schizophr Res 2009;115:97–103.
   PubMed Web of Science ®Google Scholar
• Citrome L, Jaffe A, Levine J, Lindenmayer JP. Dosing of quetiapine in schizophrenia: how clinical practice differs from registration studies. J Clin Psychiatry 2005;66: 1512–6.
   PubMed Web of Science ®Google Scholar
• Emsley R, Oosthuizen PP, Kidd M, Koen L, Niehaus DJ, Turner HJ. Remission in first-episode psychosis: predictor variables and symptom improvement patterns. J Clin Psychiatry 2006;67:1707–12.
   PubMed Web of Science ®Google Scholar
• Emsley R, Rabinowitz J, Medori R; Early Psychosis Global Working Group. Remission in early psychosis: rates, predictors, and clinical and functional outcome correlates. Schizophr Res (Netherlands) 2007;89:129–39.
   PubMed Web of Science ®Google Scholar
• Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Moller HJ. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia. World J Biol Psychiatry 2005;6:132–91.
   PubMed Web of Science ®Google Scholar
• Green AI, Lieberman JA, Hamer RM, Glick ID, Gur RE, Kahn RS et al.; HGDH Study Group. Olanzapine and haloperidol in first episode psychosis: two-year data. Schizophr Res 2006;86:234–43.
   PubMed Web of Science ®Google Scholar
• Jäger M, Riedel M, Schmauss M, Laux G, Pfeiffer H, Naber D, et al. Prediction of symptom remission in schizophrenia during inpatient treatment. World J Biol Psychiatry 2007;1–9, First article, doi: 10.1080/156229707015410549.
   Google Scholar
• Lambert M, Naber D, Schacht A, Wagner T, Hundemer HP, Karow A, et al. Rates and predictors of remission and recovery during 3 years in 392 never-treated patients with schizophrenia. Acta Psychiatr Scand 2008;118:220–9.
   PubMed Web of Science ®Google Scholar
• Larsen TK, Melle I, Auestad B, Friis S, Haahr U, Johannessen JO, et al. Early detection of first episode psychosis: the effect on 1-year outcome. Schizophr Bull 2006;32:758–64.
   PubMed Web of Science ®Google Scholar
• Lasser RA, Bossie CA, Gharabawi GM, Kane JM. Remission in schizophrenia: results from a 1-year study of long-acting risperidone injection. Schizophr Res 2005;77: 215–27.
   PubMed Web of Science ®Google Scholar
• Leucht S, Busch R, Kissling W, Kane JM. Early prediction of antipsychotic nonresponse among patients with schizophrenia. J Clin Psychiatry 2007;68:352–60.
   PubMedGoogle Scholar
• Loebel AD, Lieberman JA, Alvir JM, Mayerhoff DI, Geisler SH, Szymanski SR. Duration of psychosis and outcome in first-episode schizophrenia. Am J Psychiatry 1992;149:1183–8.
   PubMed Web of Science ®Google Scholar
• Melle I, Larsen TK, Haahr U, Friis S, Johannesen JO, Opjordsmoen S, et al. Prevention of negative symptom psychopathologies in first-episode schizophrenia: two-year effects of reducing the duration of untreated psychosis. Arch Gen Psychiatry 2008;65:634–40.
   PubMed Web of Science ®Google Scholar
• Menezes NM, Malla AM, Norman RM, Archie S, Roy P, Zipursky RB. A multi-site Canadian perspective: examining the functional outcome from first-episode psychosis. Acta Psychiatr Scand 2009;120:138–46.
   PubMed Web of Science ®Google Scholar
• Mitford E, Reay R, McCabe K, Paxton R, Turkington D. Ageism in first episode psychosis. Int J Geriatr Psychiatry 2010;25:1112–18.
   PubMed Web of Science ®Google Scholar
• Peuskens J, Kaufman L, Van Vleymen B. Analysis of resolution criteria in patients with schizophrenia treated with olanzapine for an acute psychotic episode. Schizophr Res 2007;95:169–73.
   PubMedGoogle Scholar
• Potkin SG, Weiden PJ, Loebel AD, Warrington LE, Watsky EJ, Siu CO. Remission in schizophrenia: 196-week, double-blind treatment with ziprasidone vs. haloperidol. Int J Neuropsychopharmacol 2009;12:1233–48.
   PubMed Web of Science ®Google Scholar
• Sorbara F, Liraud F, Assens F, Abalan F, Verdoux H. Substance use and the course of early psychosis: a 2-year follow-up of first-admitted subjects. Eur Psychiatry 2003;18: 133–6.
   PubMed Web of Science ®Google Scholar
• Wobrock T, Köhler J, Klein P, Falkai P. Achieving symptomatic remission in out-patients with schizophrenia -a naturalistic study with quetiapine. Acta Psychiatr Scand 2009;120: 120–8.
   PubMedGoogle Scholar
• Wunderink L, Sytema S, Nienhuis FJ, Wiersma D. Clinical recovery in first-episode psychosis. Schizophr Bull 2009;35: 362–9.
   PubMed Web of Science ®Google Scholar